Please note that Capital Advisors Group’s research is intended for institutional investors only.
Our research is for personal, non-commercial use only. You may not copy, distribute or modify content contained on this Website without prior written authorization from Capital Advisors Group. By viewing this Website and/or downloading its content, you agree to the Terms of Use.
- Page 1 of 15 >
| DATE | TITLE |
CATEGORY |
| 08/25/2020 | State of the Market: Debt Financing for Clinical Stage, Publicly Traded Life Sciences Companies |
Debt Finance Consulting |
| 07/09/2020 | Liquidity in Question – What Do We Do with Prime Money Market Funds? |
Investment Management |
| 05/14/2020 | Investment Management | |
| 04/08/2020 | Credit & Risk Management | |
| 03/20/2020 | Understanding Early-Stage Debt Financing: Why Good Deals Turn Bad |
Debt Finance Consulting |
| 02/13/2020 | How to Assess the Coronavirus Outbreak’s Impact on Liquidity Portfolios |
Investment Management |
| 01/13/2020 | Investment Management | |
| 12/20/2019 | Investment Management | |
| 11/13/2019 | Three and Done? Implications for Institutional Cash Portfolios |
Investment Management |
| 10/18/2019 | Investment Management | |
| 09/26/2019 | Investment Management | |
| 09/16/2019 | WHEN, WHY and HOW MUCH: Common Misconceptions in Early-Stage Debt Financing |
Debt Finance Consulting |
| 08/22/2019 | Investment Management | |
| 07/10/2019 | Do BBB Corporate Bonds Belong in Treasury Management Portfolios? |
Investment Management |
| 06/14/2019 | Investment Management |
- Results 1-15 of 219
- Page 1 of 15 >
